Sanofi India
Price
Prix
Dividendes historiques et prévisions
Sanofi India a jusqu'à présent distribué 2,01 en 2024. Le prochain dividende sera payé le 20.03.2025
GRAPH PAR
Questions fréquentes
Quelle est la capitalisation boursière de Sanofi India ?
Quel est le ratio cours/bénéfice (P/E) de Sanofi India ?
Quel est le bénéfice par action (BPA) de Sanofi India ?
Quelles sont les évaluations des analystes et le prix cible de l'action Sanofi India ?
Quel est le chiffre d'affaires de Sanofi India sur les douze derniers mois ?
Quel est l'EBITDA de Sanofi India ?
Quel est le bêta à 5 ans de l'action Sanofi India ?
Combien d'employés compte Sanofi India, et à quel secteur d'activité appartient-elle ?
Quel est le flottant des actions de Sanofi India ?
Finances
Capitalisation boursière
1,66 Md $USbêta sur 5 ans
0,62BPA (TTM)
2,364Free Float
9,08 MRatio P/E (TTM)
30,44Recettes (TTM)
259,61 M $USEBITDA (TTM)
66,30 M $USNotes des analystes
L'objectif de prix est de 110,64 $US et l'action est analysée par 3 analystes.
Acheter
2
Hold
0
Vendre
1
Informations
Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.
2 174
Biotechnology & Drugs
Soins de santé
Identifiant
ISIN
Ticker primaire